Letrozole is an orally active, potent, selective, nonsteroidal, third-generation aromatase (CYP19A1) inhibitor, a synthetic benzyltriazole derivative, which is used in the construction of animal models of polycystic ovary syndrome (PCOS), as well as in studies related to postoperative hormone-responsive breast cancer.
Molecular Weight:
285.30
Purity:
99.96%
CAS Number:
[112809-51-5]
Formula:
C17H11N5
Target:
Animal Modeling
* VAT and and shipping costs not included. Errors and price changes excepted